Review paper

Transitioning patients with immune thrombocytopenia to second‐line therapy: Challenges and best practices

Volume: 93, Issue: 6, Pages: 816 - 823
Published: Apr 15, 2018
Abstract
In patients with immune thrombocytopenia who do not adequately respond to first‐line therapy, there is no clear consensus on which second‐line therapy to initiate and when. This situation leads to suboptimal approaches, including prolonged exposure to treatments that are not intended for long‐term use (eg, corticosteroids) and overuse of off‐label therapies (eg, rituximab) while approved, more efficacious options exist. These approaches may not...
Paper Details
Title
Transitioning patients with immune thrombocytopenia to second‐line therapy: Challenges and best practices
Published Date
Apr 15, 2018
Volume
93
Issue
6
Pages
816 - 823
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.